pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 368 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 2
    NT-101
    Wet (Neovascular / Exudative) Macular Degeneration NexThera Co Ltd
  • Phase 1
    NVK-029
    Presbyopia Vyluma Inc
  • Phase 1
    NVK-031
    Unspecified Ophthalmological Disorders Vyluma Inc
  • Preclinical
← prev
page 7 of 13
next →
Pain89
Neurology1
NVX-101
rifampicin
Age Related Macular Degeneration
NeoVascularX Inc
  • Preclinical
    NouvSight-001
    Diabetic Retinopathy iRegene Therapeutics Co Ltd
  • Phase 1
    OCU-200
    Diabetic Macular Edema$OCGN Ocugen, Inc.
  • Phase 2
    OCU-410
    Geographic Atrophy$OCGN Ocugen, Inc.
  • Phase 3
    OCU-410ST
    Juvenile Macular Degeneration (Stargardt Disease)$OCGN Ocugen, Inc.
  • Phase 1
    OLX-301A
    Dry (Atrophic) Macular Degeneration Laboratoires Thea SA
  • Phase 2
    OPCT-001
    Retinal Degeneration BlueRock Therapeutics LP
  • Phase 2
    OPGx-BEST1
    Macular Degeneration$IRD Opus Genetics, Inc.
  • Preclinical
    OPGx-CNGB1
    Retinitis Pigmentosa (Retinitis)$IRD Opus Genetics, Inc.
  • Phase 3
    OPGx-LCA5
    Leber Congenital Amaurosis (LCA)$IRD Opus Genetics, Inc.
  • Preclinical
    OPGx-RDH12
    Leber Congenital Amaurosis (LCA)$IRD Opus Genetics, Inc.
  • Preclinical
    OPGx-RHO
    Retinitis Pigmentosa (Retinitis)$IRD Opus Genetics, Inc.
  • Preclinical
    OT-004
    Leber Congenital Amaurosis (LCA) Odylia Therapeutics Inc
  • Phase 2
    OpRegen
    OpRegen
    Geographic Atrophy F. Hoffmann-La Roche Ltd
  • Phase 2
    Optiquel
    Optiquel
    Non-infectious Uveitis Enzo Biochem Inc
  • Phase 2
    PER-001
    Diabetic Retinopathy Perfuse Therapeutics Inc
  • Phase 3
    PL-9643
    Keratoconjunctivitis Sicca (Dry Eye)$PTNT PALATIN TECHNOLOGIES INC
  • Preclinical
    PV-305
    Keratitis VisiRose Inc
  • Preclinical
    Peroxidases
    Dry (Atrophic) Macular Degeneration Ichor Life Sciences Inc
  • Phase 3
    Pollinex Quattro Grass
    Pollinex
    Allergic Rhino-Conjunctivitis Allergy Therapeutics Plc
  • Preclinical
    Protearin
    Protearin
    Keratoconjunctivitis Sicca (Dry Eye) Proteris Biotech Inc
  • Preclinical
    RBIO-101
    no indication Reflection Biotechnologies Ltd
  • Phase 1
    RCI-001
    Keratoconjunctivitis Sicca (Dry Eye) Rudacure Co Ltd
  • Preclinical
    REV-0100
    Juvenile Macular Degeneration (Stargardt Disease) ReVision Therapeutics Inc
  • Phase 2
    RG-6351
    Diabetic Macular Edema Genentech Inc
  • Preclinical
    RO-104
    Wet (Neovascular / Exudative) Macular Degeneration RevOpsis Therapeutics Inc
  • Phase 2
    RPESCRPE-4W
    Dry (Atrophic) Macular Degeneration Luxa Biotechnology LLC